DaShenLin Pharmaceutical Group Co., Ltd. announced earnings results for the nine months ended September 30, 2020. For the nine months, the company announced sales was CNY 10,492.222 million compared to CNY 8,040.587 million a year ago. Operating income was CNY 1,186.379 million compared to CNY 741.819 million a year ago. Net income was CNY 867.055 million compared to CNY 556.174 million a year ago. Basic earnings per share from continuing operations was CNY 1.32 compared to CNY 0.88 a year ago.